Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_762e1a85299db24fb96261dcdda17f0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_491fdc2d1e2d145cba2611c78d64b143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e44d589cfaa1018c81703031867fbc55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79071da8863766fdf962f0a72dd8317a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-885 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
filingDate |
1996-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2304e90bc77b9c6ab6a534336e1c68d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5cc6228102b336ed995bc3c35bd2129 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81fd4f6560a0437c4fbbaaec3fb7976f |
publicationDate |
1997-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9709438-A1 |
titleOfInvention |
Process for modifying glucose repression |
abstract |
The present invention relates to recombinant-DNA-technology, and particularly to genes involved in the control of basic metabolic processes in fungi. The invention specifically provides a mutated form of the native glucose repressor gene cre of filamentous fungi, wherein the mutation is situated in the C-terminal domain, the N-terminal first zinc finger being intact and the C-terminal region including the second zinc finger being mutated so that the viability of a strain carrying said mutated gene is maintained and the glucose repression is relieved. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8673618-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916363-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551751-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8268585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2505651-A2 |
priorityDate |
1995-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |